News & Blog
Intellectual Property - News & Media
Lenczner Slaght has once again been recognized as a top patent contentious firm in Canada by the 2018 Managing Intellectual Property’s IP STARS publication, a leading guide to the world’s foremost IP firms and practitioners.
Canada’s leading litigation firm is once again recognized in the area of Dispute Resolution by this world-renowned directory alongside notable full-service, national and international firms.
Google v. Equustek Solutions, 2017 SCC 34 is ranked second in Lexpert's Top 10 Business Decisions of 2017. Lenczner Slaght's William C. McDowell and Scott Rollwagen are mentioned as counsel to Google Inc.
Canada’s leading litigation firm continues to add exceptional litigators to its IP talent portfolio.
Along with the firm’s Tier 1 ranking in Dispute Resolution with four leading lawyers and one next generation lawyer recognized, Lenczner Slaght is also ranked in Intellectual Property, Labour and Employment, and Competition and Antitrust.
Lenczner Slaght is proud to be named as “the foremost litigation team in the country” by Who’s Who Legal: Canada 2017, with six of our expert litigators recognized for their exceptional work representing clients.
Canada’s leading litigation firm is delighted to announce that its IP team won three awards at the 2017 LMG Life Sciences Awards, where the preeminent lawyers and law firms in the US and Canada were recognized for their work in the life sciences industry.
Sana Halwani is mentioned in an article in The Star regarding an action for copyright infringement in fine art photographs taken by the posthumously-discovered photographer Vivian Maier. Sana is counsel to the Stephen Bulger Gallery in this case.
Almost half of the leading litigation firm’s lawyers are recognized in the Best Lawyers in Canada.
Lenczner Slaght is proud to announce that our IP team is a finalist in three major awards at the 2017 LMG Life Sciences Awards, recognizing leading lawyers and law firms in the US, Canada and Europe that have made a significant impact in the life sciences industry.